# Lombard Medical and MicroPort announce strategic partnership and investment

Lombard Medical and MicroPort Scientific Corporation announced a strategic partnership and $15 million investment by MicroPort, including exclusive marketing rights for Aorfix and Altura stent grafts in China and Brazil, and a component supply agreement.

- Type: Partnership
- Announced: 2016-12-19
- Where: Shanghai, China
- Value: $15.0M
- Status: announced
- Products: Aorfix stent graft, Altura stent graft
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lombard Medical](https://endata.com/companies/20848.md)
- [MicroPort Scientific Corporation](https://endata.com/companies/20849.md) (partner)

## Sources

- [vascularnews.com](https://vascularnews.com/lombard-medical-and-microport-announce-strategic-partnership-and-investment-agreement/), 2016-12-19: "The strategic partnership with MicroPort benefits all Lombard stakeholders, including physicians and their patients, our employees and, we believe, our shareholders."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.